Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care?
Joan Trujols, Antonio Larrabeiti, Oriol Sànchez, et al.
Journal of Substance Abuse Treatment (2020) Vol. 119, pp. 108154-108154
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Overview of SARS-CoV-2 infection in adults living with HIV
Juan Ambrosioni, José Luís Blanco, Juliana Reyes‐Urueña, et al.
The Lancet HIV (2021) Vol. 8, Iss. 5, pp. e294-e305
Open Access | Times Cited: 182
Early innovations in opioid use disorder treatment and harm reduction during the COVID-19 pandemic: a scoping review
Noa Krawczyk, Adetayo Fawole, Jenny Yang, et al.
Addiction Science & Clinical Practice (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 79
The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era
Ofer Amram, Solmaz Amiri, Victoria Panwala, et al.
The American Journal of Drug and Alcohol Abuse (2021) Vol. 47, Iss. 6, pp. 722-729
Closed Access | Times Cited: 78
Changes in methadone take-home dosing before and after COVID-19
Ofer Amram, Solmaz Amiri, Emily Thorn, et al.
Journal of Substance Abuse Treatment (2021) Vol. 133, pp. 108552-108552
Open Access | Times Cited: 43
“The Idea is to Help People Achieve Greater Success and Liberty”: A Qualitative Study of Expanded Methadone Take-Home access in Opioid use Disorder Treatment
Leslie W. Suen, Stacy Castellanos, Neena Joshi, et al.
Substance Abuse (2022) Vol. 43, Iss. 1, pp. 1147-1154
Open Access | Times Cited: 36
Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis
Ximena A. Levander, Kim Hoffman, John W. McIlveen, et al.
Addiction Science & Clinical Practice (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 35
The impact of COVID-19 on substance use disorder treatment in California: Service providers' perspectives
Chunqing Lin, Sarah E. Clingan, Sarah J. Cousins, et al.
Journal of Substance Abuse Treatment (2021) Vol. 133, pp. 108544-108544
Open Access | Times Cited: 33
Methadone exposures reported to poison control centers in the United States following the COVID-19-related loosening of federal methadone regulations
Christopher Welsh, Suzanne Doyon, Katherine Hart
International Journal of Drug Policy (2022) Vol. 102, pp. 103591-103591
Open Access | Times Cited: 26
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
Daniyar Aldabergenov, Laura Reynolds, Jenny Scott, et al.
International Journal of Drug Policy (2022) Vol. 110, pp. 103877-103877
Open Access | Times Cited: 25
Endogenous opiates and behavior: 2020
Richard J. Bodnar
Peptides (2022) Vol. 151, pp. 170752-170752
Closed Access | Times Cited: 19
“You'll come in and dose even in a global pandemic”: A qualitative study of adaptive opioid agonist treatment provision during the COVID-19 pandemic
Anna Conway, Carla Treloar, Sione Crawford, et al.
International Journal of Drug Policy (2023) Vol. 114, pp. 103998-103998
Open Access | Times Cited: 10
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023
Gráinne Cousins, Louise Durand, Kathleen Bennett, et al.
HRB Open Research (2025) Vol. 8, pp. 32-32
Open Access
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023
Gráinne Cousins, Louise Durand, Kathleen Bennett, et al.
HRB Open Research (2025) Vol. 8, pp. 32-32
Open Access
The impact of COVID‐19 on alcohol and other drug nurses' provision of care: A qualitative descriptive study
Adam Searby, Dianna Burr
Journal of Clinical Nursing (2021) Vol. 30, Iss. 11-12, pp. 1730-1741
Open Access | Times Cited: 22
An Ethnographic Assessment of COVID-19‒Related Changes to the Risk Environment for People Who Use Drugs in Tijuana, Mexico
Joseph Friedman, Alhelí Calderón-Villarreal, Rebeca Cazares Adame, et al.
American Journal of Public Health (2022) Vol. 112, Iss. S2, pp. S199-S205
Open Access | Times Cited: 16
Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA
Magally Torres-Leguizamon, Jamie Favaro, Dan Coello, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 9
Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study
Gemma Scott, Sophie Turner, Natalie Lowry, et al.
BMJ Open (2023) Vol. 13, Iss. 3, pp. e069857-e069857
Open Access | Times Cited: 9
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis
M. Eugenia Socías, Jin Cheol Choi, Nadia Fairbairn, et al.
International Journal of Drug Policy (2023) Vol. 118, pp. 104075-104075
Open Access | Times Cited: 6
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences
Rebecca McDonald, Anne Berit Bech, Thomas Clausen
BMC Health Services Research (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Understanding the Impacts of Novel Coronavirus Outbreaks on People Who Use Drugs: A Systematic Review to Inform Practice and Drug Policy Responses to COVID-19
Alison Munro, Hazel Booth, Nicola Gray, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 16, pp. 8470-8470
Open Access | Times Cited: 11
Satisfaction of patients on methadone maintenance treatment with changing policies during the COVID-19 pandemic
Anat Sason, Marsha Weinstein, Miriam Adelson, et al.
Heroin addiction and related clinical problems (2024), pp. 1-8
Closed Access | Times Cited: 1
Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in Kenya: a qualitative study
Sarah Kanana Kiburi, Jackline Mwangi, Geoffrey Maina
Addiction Science & Clinical Practice (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 5
The impact of the COVID-19 lockdown on services for substance use in Denmark: Implications for meeting users’ needs and recommendations for the future
Adriana del Palacio‐González, Birgitte Thylstrup, Esben Houborg
Nordic Studies on Alcohol and Drugs (2022) Vol. 39, Iss. 2, pp. 175-189
Open Access | Times Cited: 4
“The idea is to help people achieve greater success and liberty”: a qualitative study of expanded methadone take-home access in opioid use disorder treatment
Leslie W. Suen, Stacy Castellanos, Neena Joshi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Outcomes Associated with Expanded Take-Home Eligibility for Outpatient Treatment with Medications for Opioid Use Disorder: A Mixed-Methods Analysis
Oanh Kieu Nguyen, Scott Steiger, Hannah Snyder, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top